Definitive Healthcare Corp. (DH) Fair Value 2026

DH · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.0 /10

32 fundamental signals · 3 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-28, Definitive Healthcare Corp. (DH) trades at $0.80, versus a $2.87 median fair value across its 3 active models — 257.4% above the current price. QOC: 7.0/10. Value Trap Risk: 13/100 (SAFE). 3/13 models active.

Key Facts

Ticker
DH
Price
$0.80
Quality Score
7.0/10
Value Trap Risk
13/100
Models Active
3/13
Last Updated
Strength: Regime Cross-Sectional suggests +442.4% upside with 45% confidence
Risk: Limited model coverage (3/13) may reduce confidence

Is Definitive Healthcare Corp. (DH) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, Definitive Healthcare Corp. (DH) appears undervalued as of : the median of 3 independent fair value estimates is $2.87, 257.4% above the current price of $0.80. Estimates range from $0.46 to $4.35. DH scores 7.0/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. DH’s +257.4% gap is wider than that market norm, and the Health Information Services sector median is +4.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Definitive Healthcare Corp. Stock in 2026? →

What Fair Value Does Each Model Give DH?

3 Intrinsic Value Models vs. Current Price ($0.80)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.46 -42.5%
Relative · Medium Conviction
 $4.35 +442.4%
Option-Based · Medium Conviction
 $2.87 +257.4%

All Models Active

All 3 models are displayed above.

What Is DH's Fair Value Range?

Spread across 3 independent models · $0.46 to $4.35

CirclFi's 3 active models place Definitive Healthcare Corp. (DH) between $0.46 and $4.35 per share, a spread of 136% of the median. The median of that range — $2.87 — is the fair value CirclFi publishes for DH, against a current price of $0.80.

Low · ML-RIVHigh · Regime Cross
$0.46median $2.87$4.35
Where the range comes from
Most bearish modelML Residual Income$0.46
Most bullish modelRegime Cross-Sectional$4.35
Model agreement2 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for DH. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on DH, not a CirclFi price target. How each model works →

What Is Definitive Healthcare Corp. (DH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Definitive Healthcare Corp.'s intrinsic value is estimated at $2.87, suggesting a +257.4% median upside from the current price of $0.80. While 2 models see room for appreciation, model agreement is not unanimous as 1 model flags potential overvaluation. Model dispersion is worth noting: Regime Cross targets $4.35 (+442.4%), versus ML-RIV at $0.46 (-42.5%). This +484.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About DH?

3 of 13 models are currently active for DH. Of these, 2 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for DH is $2.87 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does DH Rank in Health Information Services?

Among 55 Health Information Services stocks, DH ranks #22 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.

See all Most Undervalued Health Information Services Stocks →

Definitive Healthcare Corp. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is DH a Value Trap?

CirclFi's Value Trap algorithm assigns DH a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for Definitive Healthcare Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Definitive Healthcare Corp. earns a quality score of 7.0/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +484.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DH's 3 active models, average confidence is 45%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Definitive Healthcare Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

NRCNRC HealthQOC 7.0TALKTalkspace IncQOC 7.0SDGRSchrödinger, Inc.QOC 7.1WEAVWeave Communications, Inc.QOC 6.6BTSGBrightSpring Health Services, Inc.QOC 7.2SYSo-Young International Inc.QOC 6.5SOPHSOPHiA GENETICS SAQOC 5.9RVRCRevium Rx.QOC 4.5CCLDCareCloud, Inc.QOC 8.4DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: NRC · TALK · SDGR · WEAV · BTSG · SY · SOPH · RVRC · CCLD · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to DH?

5 companies across all industries closest to DH’s Quality of Company score of 7.0/10.

AOUTAmerican Outdoor Brands, Inc.QOC 7.0RVSBRiverview Bancorp, Inc.QOC 7.0WECWEC Energy Group, Inc.QOC 7.0EVLVEvolv Technologies Holdings, Inc.QOC 7.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AOUT · RVSB · WEC · EVLV · NVDA

Where Does DH Sit in CirclFi's Health Information Services Rankings?

DH is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Definitive Healthcare Corp.’s Valuation?

What is Definitive Healthcare Corp.'s intrinsic value in 2026?

CirclFi puts Definitive Healthcare Corp. (DH)'s intrinsic value at $2.87 — the median of 3 independent model estimates as of 2026-08-28, ranging from $0.46 to $4.35. The Quality of Company score is 7.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DH overvalued or undervalued right now?

At $0.80, 2 of 3 active models suggest DH may be undervalued, while 1 indicate potential overvaluation. The median of all 3 fair value estimates is $2.87, 257.4% above the current price of $0.80 — a consensus view that DH is undervalued. The assessment depends on which methodology best fits Definitive Healthcare Corp.'s business model in Health Information Services.

What does a Quality of Company score of 7.0 mean for DH?

Definitive Healthcare Corp.'s QOC of 7.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on DH?

CirclFi analyzes DH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on DH?

Of the 3 models currently active on DH, Regime Cross-Sectional is the most bullish at $4.35 per share, and ML Residual Income is the most bearish at $0.46. CirclFi's published fair value for DH is the median of that range, $2.87, not either extreme. The gap between the two ends equals 136% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is DH a value trap in 2026?

Definitive Healthcare Corp.'s Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 3-model valuation engine, Definitive Healthcare Corp. (DH) has a median fair value of $2.87 — 257.4% above the current price of $0.80 — as of 2026-08-28.” Source: circlfi.com/stock/DH/ · Methodology
Primary sources for this DH valuation
  • Financial statements: Definitive Healthcare Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001861795) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for DH as of ; valuations recomputed .